Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture

Overview

Journal Biomark Insights

Publisher Sage Publications

Date 2015 Jun 9

PMID 26052225

Citations 56

Authors

Ivan Batalov

Adam W Feinberg

Affiliations

Soon will be listed here.

Abstract

Human pluripotent stem cells (PSCs) are a promising cell source for cardiac tissue engineering and cell-based therapies for heart repair because they can be expanded in vitro and differentiated into most cardiovascular cell types, including cardiomyocytes. During embryonic heart development, this differentiation occurs under the influence of internal and external stimuli that guide cells to go down the cardiac lineage. In order to differentiate PSCs in vitro, these or similar stimuli need to be provided in a controlled manner. However, because it is not possible to completely recapitulate the embryonic environment, the factors essential for cardiac differentiation of PSCs in vitro need to be experimentally determined and validated. Since PSCs were first developed, significant progress has been made in optimizing techniques for their differentiation toward cardiomyocytes. In this review, we will summarize recent advances in these techniques, with particular focus on monolayer-based methods that have improved the efficiency and scalability of cardiomyocyte differentiation.

Citing Articles

Modeling immune checkpoint inhibitor associated myocarditis and its therapeutic implications.

Jensen G, Wang X, Kuempel J, Chen Z, Yu W, Palaskas N J Mol Cell Cardiol Plus. 2025; 10.

PMID: 39742339 PMC: 11687339. DOI: 10.1016/j.jmccpl.2024.100122.

Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration.

Huang Y, Wang T, Lopez M, Hirano M, Hasan A, Shin S Microphysiol Syst. 2024; 4:2.

PMID: 39430371 PMC: 11488690. DOI: 10.21037/mps-20-3.

Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model.

Sleiman Y, Reisqs J, Boutjdir M Int J Mol Sci. 2024; 25(17).

PMID: 39273104 PMC: 11394733. DOI: 10.3390/ijms25179155.

Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: approaches and challenges.

Farboud S, Fathi E, Valipour B, Farahzadi R J Transl Med. 2024; 22(1):783.

PMID: 39175068 PMC: 11342568. DOI: 10.1186/s12967-024-05499-8.

Targeting the I Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants.

Zhong L, Yan Z, Jiang D, Weng K, Ouyang Y, Zhang H Circ Res. 2024; 135(7):722-738.

PMID: 39166328 PMC: 11392204. DOI: 10.1161/CIRCRESAHA.124.325009.

References

Robertson C, Tran D, George S . Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013; 31(5):829-37. PMC: 3749929. DOI: 10.1002/stem.1331. View

Otsuji T, Minami I, Kurose Y, Yamauchi K, Tada M, Nakatsuji N . Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 2010; 4(3):201-13. DOI: 10.1016/j.scr.2010.01.002. View

Gupta M, Illich D, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K . Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol. 2010; 10:98. PMC: 2946283. DOI: 10.1186/1471-213X-10-98. View

Kim H, Lee K, Kim D, Hwang D . An ECM-based culture system for the generation and maintenance of xeno-free human iPS cells. Biomaterials. 2012; 34(4):1041-50. DOI: 10.1016/j.biomaterials.2012.10.064. View

Laflamme M, Chen K, Naumova A, Muskheli V, Fugate J, Dupras S . Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25(9):1015-24. DOI: 10.1038/nbt1327. View

Mummery C, Zhang J, Ng E, Elliott D, Elefanty A, Kamp T . Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012; 111(3):344-58. PMC: 3578601. DOI: 10.1161/CIRCRESAHA.110.227512. View

Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S . Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res. 2013; 112(3):523-33. DOI: 10.1161/CIRCRESAHA.111.256149. View

Lee Y, Ng K, Lai W, Chan Y, Lau Y, Lian Q . Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev Rep. 2011; 7(4):976-86. PMC: 3226695. DOI: 10.1007/s12015-011-9273-3. View

Evans M, Kaufman M . Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819):154-6. DOI: 10.1038/292154a0. View

10.

Agarwal A, Goss J, Cho A, McCain M, Parker K . Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip. 2013; 13(18):3599-608. PMC: 3786400. DOI: 10.1039/c3lc50350j. View

11.

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2013; 129(3):e28-e292. PMC: 5408159. DOI: 10.1161/01.cir.0000441139.02102.80. View

12.

Place E, Evans N, Stevens M . Complexity in biomaterials for tissue engineering. Nat Mater. 2009; 8(6):457-70. DOI: 10.1038/nmat2441. View

13.

Guenther M, Frampton G, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R . Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell. 2010; 7(2):249-57. PMC: 3010384. DOI: 10.1016/j.stem.2010.06.015. View

14.

Nunes S, Miklas J, Radisic M . Maturation of stem cell-derived human heart tissue by mimicking fetal heart rate. Future Cardiol. 2013; 9(6):751-4. DOI: 10.2217/fca.13.71. View

15.

Bhatia S, Ingber D . Microfluidic organs-on-chips. Nat Biotechnol. 2014; 32(8):760-72. DOI: 10.1038/nbt.2989. View

16.

Feinberg A, Ripplinger C, van der Meer P, Sheehy S, Domian I, Chien K . Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes. Stem Cell Reports. 2013; 1(5):387-96. PMC: 3841251. DOI: 10.1016/j.stemcr.2013.10.004. View

17.

Passier R, Ward-van Oostwaard D, Snapper J, Kloots J, Hassink R, Kuijk E . Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells. 2005; 23(6):772-80. DOI: 10.1634/stemcells.2004-0184. View

18.

Moran A, Forouzanfar M, Roth G, Mensah G, Ezzati M, Murray C . Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014; 129(14):1483-92. PMC: 4181359. DOI: 10.1161/CIRCULATIONAHA.113.004042. View

19.

Segers V, Lee R . Stem-cell therapy for cardiac disease. Nature. 2008; 451(7181):937-42. DOI: 10.1038/nature06800. View

20.

Beltrami A, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S . Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114(6):763-76. DOI: 10.1016/s0092-8674(03)00687-1. View